Showing results (1601-1610 of 1,686) with videos related to

Sort By:
Pageof 169
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
Journal of the American College of Cardiology|September 19, 2003
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) StudyDavid J Moliterno, James B Hermiller, Dean J Kereiakes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2006
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removalWarren J Cantor, Kenneth W Mahaffey, Zhen Huang, et al.
The American Journal of Cardiology|October 24, 2006
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Jyotsna Mulgund, et al.
Nature Medicine|September 14, 2023
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trialJennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk, et al.
JACC. Cardiovascular Interventions|March 11, 2022
Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid PatientsG Michael Deeb, Michael J Reardon, Basel Ramlawi, et al.
The American Journal of Cardiology|April 28, 2004
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)A Michael Lincoff, John A Bittl, Neal S Kleiman, et al.
JACC. Cardiovascular Interventions|July 24, 2024
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid StudyFiras Zahr, Basel Ramlawi, Michael J Reardon, et al.
The Annals of Thoracic Surgery|January 9, 2018
Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve ReplacementG Michael Deeb, Stanley J Chetcuti, Steven J Yakubov, et al.
Circulation|February 18, 1997
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI InvestigatorsE M Ohman, N S Kleiman, G Gacioch, et al.
Pageof 169